SecBot SecBot
8-K ·Filed Jun 1, 2026

IFF

INTERNATIONAL FLAVORS & FRAGRANCES INC
BULLISH
Impact 7/10
Horizonmonths Processed5mo ago SEC0001193125-26-249963
8-K material event: Items 1.01
Actionable Insight ▲ Bullish

The divestiture simplifies IFF's portfolio to higher-growth Taste, Scent, and Health & Biosciences segments. The ~$3.8B cash inflow enables significant deleveraging and potential buybacks. Monitor regulatory timeline and Q2 2027 close; near-term EPS dilution is a headwind but the strategic refocusing and balance sheet improvement are positive catalysts. The reiterated 2026 guidance provides a floor for expectations.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$74.26
T+0 close · Jun 1, 2026 · via day close
Latest settled
+17.37%
T+60 · $87.16
Vs SPY
+16.14%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 1 $74.26entry
  2. T+1 · 6mo ago −1.37%α −1.52% · $73.24
  3. T+5 · 5mo ago −1.68%α +1.07% · $73.01
  4. T+20 · 5mo ago +6.68%α +7.98% · $79.22
  5. T+60 · 3mo ago +17.37%α +16.14% · $87.16
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

IFF entered into a definitive agreement to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion (enterprise value), representing a ~10x EBITDA multiple. IFF expects net cash proceeds of ~$3.8 billion at closing and will retain a ~9.9% minority equity interest valued at ~$200 million. The transaction is expected to close by end of Q2 2027 and is dilutive to adjusted EPS in the first 12 months post-close.

Key Financial Metrics

Deal Value
$4.3B
Deal Type
acquisition

Key Facts

  • IFF agreed to sell its Food Ingredients business to CVC Capital Partners for ~$4.3 billion enterprise value (~10x EBITDA).
  • IFF expects net cash proceeds of ~$3.8 billion at closing, plus a ~9.9% minority equity interest valued at ~$200 million.
  • The Food Ingredients business generated ~$3.1 billion in sales and ~$430 million in EBITDA in 2025.
  • Proceeds will be prioritized for debt reduction, targeted share repurchases, and reinvestment in core businesses.
  • Transaction expected to close by end of Q2 2027, subject to regulatory approvals and customary conditions.
  • IFF reiterated full-year 2026 guidance: sales $10.5B-$10.8B, adjusted operating EBITDA $2.05B-$2.15B.
  • Transaction is expected to be dilutive to adjusted EPS in the first 12 months following closing.
  • IFF has divested 13 non-core businesses including this one, generating nearly $10 billion in gross proceeds.

Financial Impact

~$4.3 billion enterprise value; ~$3.8 billion net cash proceeds; ~$200 million retained equity stake; ~10x EBITDA multiple

revenueebitdaepsdebtdilution

Risk Factors

  • Transaction expected to be dilutive to adjusted EPS in first 12 months post-close.
  • Closing not expected until end of Q2 2027, regulatory and execution risks over ~12-month period.
  • Stranded overhead costs from the carve-out could pressure margins if not fully addressed.
  • Retained minority stake (~10%) limits upside participation and introduces illiquidity.

Market Snapshot

Exchange
NYSE
Sector
Industrial Organic Chemicals
Analyst Consensus
76% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-249963
Document: d118591dex991.htm0001193125-26-249963
Document: 0001193125-26-249963-index-headers.html0001193125-26-249963
Document: 0001193125-26-249963-index.html0001193125-26-249963
Document: 0001193125-26-249963.txt0001193125-26-249963

Track record

13 reports on IFF

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 12, 20264d ago 3 Neutral 2/10 Entry $81.16 Now $79.99 −1.44% settles Feb 11
  2. Nov 3, 202613d ago 8-K Neutral 3/10 Entry $87.67 Now $79.99 −8.76% settles Feb 2
  3. Nov 3, 202613d ago 8-K Neutral 5/10 Entry $87.67 Now $79.99 −8.76% settles Feb 2
  4. Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $93.02 Now $79.99 −14.01% settles Jan 28
  5. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $90.66 Now $79.99 −11.77% settles Jan 26
  6. Sep 11, 20269w ago ANALYST-UPGRADE Neutral 2/10 Entry $83.61 Now $79.99 −4.33% settles Dec 7
  7. Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $85.00 to $87.67 Now $79.99 −5.89% ▲ +3.14% +3.63% vs SPY
  8. Jul 20, 202617w ago Press Release Neutral 3/10 Entry $76.26 to $88.20 Now $79.99 +4.89% ▲ +15.66% +11.68% vs SPY
  9. Jun 23, 202620w ago 8-K Neutral 4/10 Entry $75.83 to $84.91 Now $79.99 +5.49% ▲ +11.97% +9.14% vs SPY
  10. Jun 9, 202622w ago ANALYST-UPGRADE Bullish 3/10 Entry $75.78 to $86.94 Now $79.99 +5.56% ▲ +14.73% +10.91% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 7h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026